H.R. 1706 - Protecting Consumer Access to Generic Drugs Act of 2009
- Sponsor:
- Bobby L. Rush
- Summary:
- To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. (by CRS)
- Status:
- The bill has been introduced.
Protecting Consumer Access to Generic Drugs Act of 2009
H.R. 1706 — 111th Congress (2009–2010)
- Keywords
- Pay for delay, Generic drugs delay, Reverse settlements, Waxman-Hatch Act
- Summary
- To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. (by CRS)
- Learn More
- At OpenCongress
- Title
- To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes.
- Other Titles
- Protecting Consumer Access to Generic Drugs Act of 2009
- Sponsor
- Bobby L. Rush
- Co-Sponsors
- Subjects
- Commerce
- Administrative law and regulatory procedures
- Competition and antitrust
- Contracts and agency
- Federal Trade Commission (FTC)
- Intellectual property
- Marketing and advertising
- Prescription drugs
- Related Bills
- Major Actions
Introduced 3/25/2009 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 3/25/2009 3/25/2009 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. 3/25/2009 Referred to House Energy and Commerce 3/25/2009 Referred to House Judiciary 3/26/2009 Referred to the Subcommittee on Commerce, Trade and Consumer Protection. 6/03/2009 Subcommittee Consideration and Mark-up Session Held. 6/03/2009 Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 16 - 10 . Number Sponsor Date Offered Status
Total contributions given to House members from interest groups that…
supported this bill
Elderly issues/Social Security |
Consumer groups |
Pharmaceutical manufacturing (split) |
opposed this bill
Medical Devices & Supplies |
Pharmaceutical manufacturing (split) |
Contributions data source: OpenSecrets.org